VASOPTIC MEDICAL, INC.
Optical imaging system integrated with surgical microscope for real-time blood flow visualization during neurosurgery using laser speckle contrast imaging
- Sector
- Medtech
- Headquarters
- Baltimore, MD
- Founded
- 2012
- Latest Form D
- $1.6M, Apr 2017
- Total capital
- $12.9M
- Federal grants
- $11.1M
- 17 awards · 2015–2025
- Rank in peer group#26 of 538
- Private capital raised
- $1.8M
- 3 Form D · last Apr 2017
- 115 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 10 pending · first 2016
- Rank in peer group#97 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Imaging of Neurovascular Response for Assessment of Alzheimer's Disease$500K
- Federal grantHealth and Human S · Phase II · Ocular Blood Flow Imaging for Glaucoma Assessment$246K
- Federal grantHealth and Human S · Phase II · Ocular Blood Flow Imaging for Glaucoma Assessment$875K
- Federal grantHealth and Human S · Phase II · Dye-free, on-demand visualization of blood flow during cerebrovascular surgery$883K
- Federal grantHealth and Human S · Phase II · Ocular Blood Flow Imaging for Glaucoma Assessment$675K
- Federal grantHealth and Human S · Phase II · Dye-free, on-demand visualization of blood flow during cerebrovascular surgery$1.6M
- Federal grantHealth and Human S · Phase I · Assessment of episcleral vasculature for glaucoma management$257K
- Private capital raisedForm D · SEC · 3rd filing$1.6M
- Private capital raisedForm D · SEC · 2nd filing$250K
- Private capital raisedForm D · SEC · 1st filing$11K
Show 10 earlier federal awards
- Federal grantHealth and Human S · Phase I · Blood Flow Imaging for Minimally Invasive Surgeryhttps://apps.era.nih.gov/grantfolder/viewInternalGF.era?applId=10008550$256K
- Federal grantHealth and Human S · Phase I · Development of Flow Based Biomarkers for Retinopathy of Prematurity - Supplemental Aim$96K
- Federal grantHealth and Human S · Phase I · Development of Flow Based Biomarkers for Retinopathy of Prematurity - Supplemental Aim$389K
- Federal grantHealth and Human S · Phase I · Development of Flow Based Biomarkers for Retinopathy of Prematurity$293K
- Federal grantHealth and Human S · Phase II · Real Time Noninvasive Monitoring of Blood Flow During Surgery$742K
- Federal grantHealth and Human S · Phase II · Laser Speckle Imaging Chip for Telehealth Applications$746K
- Federal grantHealth and Human S · Phase II · Real Time Noninvasive Monitoring of Blood Flow During Surgery$1.5M
- Federal grantHealth and Human S · Phase II · Laser Speckle Imaging Chip for Telehealth Applications$1.5M
- Federal grantHealth and Human S · Phase I · Laser Speckle Imaging Chip for Telehealth Applications$340K
- Federal grantHealth and Human S · Phase I · Real time and noninvasive monitoring of blood flow during surgery$249K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#26 · top 5%
- Granted patents#97 · top 18%
- Linked publications#55 · top 10%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Abhishek Jason RegeResearcherExecutive Officer, DirectorLinked by 6 patents · $11.1M in grants as PI
- M. Jason BrookeExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 16- GrantedIllumination Of An Eye Fundus Using Non-scanning Coherent LightUSPTOUS 12,667,254
- PendingOphthalmic Examination And Disease Management With Multiple Illumination ModalitiesUSPTOApplication 18228380
- GrantedOphthalmic Examination And Disease Management With Multiple Illumination ModalitiesUSPTOUS 11,766,172
Show all 16 patent records
- Illumination Of An Eye Fundus Using Non-scanning Coherent LightJun 30, 2026 · US 12,667,254Granted
- Ophthalmic Examination And Disease Management With Multiple Illumination ModalitiesNov 23, 2023 · Application 18228380Pending
- Ophthalmic Examination And Disease Management With Multiple Illumination ModalitiesSep 26, 2023 · US 11,766,172Granted
- System And Method For Rapid Examination Of Vasculature And Particulate Flow Using Laser Speckle Contrast ImagingJun 6, 2023 · US 11,666,238Granted
- System And Method For Augmented Reality Visualization Of Biomedical Imaging DataMay 5, 2022 · Application 17427802Pending
- System And Method For Rapid Examination Of Vasculature And Particulate Flow Using Laser Speckle Contrast ImagingJun 1, 2021 · US 11,020,015Granted
- Ophthalmic Examination And Disease Management With Multiple Illumination ModalitiesJul 28, 2020 · US 10,722,116Granted
- Ophthalmic Examination And Disease Management With Multiple Illumination ModalitiesNov 15, 2016 · US 9,492,083Granted
- Method and Apparatus for Ophthalmic Examination and Disease Management with Multiple Illumination SourcesApplication 61788835Pending
- Illumination Of An Eye Fundus Using Non-scanning Coherent LightApplication PCTUS2021021695Pending
- Illumination of an Eye Fundus Using Non-Scanning Coherent LightApplication 62989224Pending
- System And Method For Augmented Reality Visualization Of Biomedical Imaging DataApplication PCTUS2020016312Pending
- System And Method For Augmented Reality Visualization Of Biomedical Imaging DataApplication 62800920Pending
- System And Method For Rapid Examination Of Vasculature And Particulate Flow Using Laser Speckle Contrast ImagingApplication PCTUS2016055976Pending
- System And Method For Rapid Examination Of Vasculature And Particulate Flow Using Laser Speckle Contrast ImagingApplication 62239529Pending
- Ophthalmic Examination And Disease Management With Multiple Illumination ModalitiesApplication PCTUS2014025014Pending
Recent research by its founders
- Retinal Blood Flow Decreases After Treatment with Laser Photocoagulation for Retinopathy of Prematurity20260 cites
- Retinal Blood Flow Decreases after Treatment with Bevacizumab for Retinopathy of Prematurity20251 cites
- Realtime assessment of vascular occlusion and reperfusion in animal models of intraoperative imaging – a pilot study20241 cites
Related companies, and why
- SENTIAR, INC.Similar federal contract value in Medtech · null in contracts
- ZETAGEN THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
- Harpoon Medical, Inc.Similar federal contract value in Medtech · null in contracts
- Nupulsecv IncSimilar federal contract value in Medtech · null in contracts
- VADOVATIONS, INC.Similar federal contract value in Medtech · null in contracts
- ABREOS BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .